Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Liquid biopsy
by Highest Patent Value in the China in 2022

The Liquid biopsy top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Liquid biopsy Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Like traditional biopsy this type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive. Therefore, it can also be done more frequently which can better track tumors and mutations over a duration of time. It may also be used to validate the efficiency of a cancer treatment drug by taking multiple liquid biopsy samples in the span of a few weeks. The technology may also prove beneficial for patients after treatment to monitor relapse.
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 155,000
2
Health care,RNA,Virus,
...[+1]
Avg patent value: 110,000
3
Avg patent value: 54,500
4
Avg patent value: 53,000
5
Avg patent value: 47,000
6
PHASE Scientific International Ltd.
Avg patent value: 32,000
7
Avg patent value: 10,166
8
Genecast Biotechnology Co. Ltd.
Avg patent value: 3,733
9
Health care,Drug,Electronic nose,
...[+2]
Avg patent value: 3,600
10
Avg patent value: 3,600
Page generation time: May 12 2025